Limula
PrivateLast Round
Debt
Dec 11, 2024
Total Funding Raised
$15.43M
Company Overview
Limula operates in Healthcare & Life Sciences and is based in Lausanne. Its latest recorded funding round was a Debt round in December 2024.
Limula is a biotechnology company that develops an automated, closed-system platform for the manufacturing of personalized cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limula Comparables
Compare Limula with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sarcura | 88% | |
| Adva Biotechnology | 87% | |
| MFX | 86% |
For institutional investors. Book with your work email.
Limula Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 11, 2024 | ||||
| Seed | May 21, 2024 | ||||
| Grant | Oct 5, 2023 | ||||
| Grant | Jun 21, 2023 | ||||
| Grant | Apr 28, 2023 | ||||
Grant | Oct 11, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Limula Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeX Ventures | Seed |
| European Innovation Council Fund | Grant |
| Foundation for Technological Innovation | Debt, Grant |
| Verve Ventures | Seed |
| LifeX Ventures | Seed |
| W.A. de Vigier Foundation | Seed |
| Swiss State Secretariat for Education, Research and Innovation (SERI) | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2026
Limula SA is developing an automated Cell and Gene Therapy manufacturing platform.
- Jun 18, 2025
Oliver Dick joins the Strategic Advisory Board.
For institutional investors. Book with your work email.
Limula Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Limula's valuation, stock price, and market status.
Is Limula a public or private company?
Limula is a private company.
What is the current stock price of Limula?
Limula is a private company, so its shares have no public market price. Caplight tracks Limula's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Limula worth (valuation)?
Valuation information for Limula is not publicly available.
Can I buy Limula stock?
Limula shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Limula's last funding round?
Limula's most recent funding round was Debt on December 11, 2024.
Who are the main investors in Limula?
Key investors in Limula include LifeX Ventures, LifeX Ventures.
Will Limula IPO soon?
No public IPO plans have been announced for Limula.
How can I track Limula secondary market activity?
Caplight tracks bids, offers, and trades in Limula's shares on secondary markets.